Loading…
Abrdn Healthcare Investors is projected to rise to $29.40 by 2027, a +36% move from its current price of $21.59. HQH is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 12 | $21.37 | $21.60 | $21.83 | +0.03% |
| Jul 13 | $21.28 | $21.60 | $21.93 | +0.07% |
| Jul 14 | $21.22 | $21.61 | $22.01 | +0.10% |
| Jul 15 | $21.16 | $21.62 | $22.09 | +0.13% |
| Jul 16 | $21.12 | $21.63 | $22.15 | +0.17% |
| Jul 17 | $21.08 | $21.63 | $22.21 | +0.20% |
| Jul 18 | $21.04 | $21.64 | $22.26 | +0.23% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $21.04 | $21.64 | $22.26 | +0.23% |
| Week 2 | $20.84 | $21.69 | $22.58 | +0.47% |
| Week 3 | $20.70 | $21.74 | $22.83 | +0.70% |
| Week 4 | $20.60 | $21.79 | $23.06 | +0.94% |
| Week 5 | $20.51 | $21.84 | $23.27 | +1.18% |
| Week 6 | $20.43 | $21.90 | $23.46 | +1.41% |
| Week 7 | $20.37 | $21.95 | $23.65 | +1.65% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries, and it invests in public equity markets across the globe. The fund primarily invests in growth stocks of small cap companies and uses fundamental analysis with a focus on factors such as current or anticipated market position for services or products, experienced business management, recognized technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio.
Abrdn Healthcare Investors was formed on October 31, 1986 and is domiciled in the United States. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index, the S&P 500 Index, and the S&P 1500 Healthcare Index.
HQH trades as a public share of a diversified healthcare-focused equity portfolio. It currently sits at $21.63 per share with a market cap of $1.24B and holds a rank of 2398 among peers.
The near-term technical picture remains bullish, with RSI(14) at 70 and prices trading above the 50-day simple moving average ($19.73) and the 200-day simple moving average ($18.95). A defined near-term support is at $18.77 and resistance at $21.22, framing the immediate risk/reward. The 30-day price range spans from $20.07 to $23.31, highlighting recent volatility within a tight band.
Annualized volatility is 20%, underscoring elevated price swings typical for a healthcare equity-focused fund with small-cap exposure. The forecast pathway shows upside over multiple years, with 2026 averaging $21.63 and climbing toward higher levels in subsequent years, including a 2030 average of $44.01 and a 2050 average of $216.10, with max prices rising to $60.03 by 2030 and $353.43 by 2050.
A major floor 20.1% below — a decisive break under it would weaken the trend.
The nearest floor, 13.1% below — buyers have tended to step in here.
Price is pressing into resistance (2.3% away) — a breakout level to watch.
A major ceiling 11.8% above — clearing it would confirm fresh momentum.
Key HQH support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of HQH market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $21.91 | Sell | $21.82 | Sell |
| MA 10 | $21.89 | Sell | $21.66 | Sell |
| MA 20 | $20.97 | Buy | $21.16 | Buy |
| MA 50 | $20.18 | Buy | $20.36 | Buy |
| MA 100 | $19.51 | Buy | $19.79 | Buy |
| MA 200 | $19.21 | Buy | $19.11 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 61.90 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | 43.62 | Neutral |
| Williams %R (14) | -26.74 | Info |
| MACD (12,26,9) | 0.04 | Buy |
| ROC (12) | 5.42 | Buy |
| Bollinger %B (20,2) | 0.65 | Neutral |
| Stochastic %K (14) | 73.26 | Neutral |
| TRIX (15) | 0.42 | Buy |
| Awesome (5,34) | 1.63 | Buy |
| Ultimate (7,14,28) | 50.00 | Neutral |
| Momentum (10) | 0.37 | Buy |
| Aroon Osc (25) | 68.00 | Buy |
| Hull MA (9) | 21.88 | Sell |
| ADX (14) | 33.09 | Buy |
| ATR (14) | 0.22 | Info |
The 30-day technical picture is bullish, with RSI(14) at 70 and the price above both the 50-day and 200-day moving averages (SMA50 is $19.73 and SMA200 is $18.95). This suggests positive momentum in the near term.
The 30-day price range runs from $20.07 to $23.31, placing the current price around the upper portion of that range. Traders might watch the noted support at $18.77 and resistance at $21.22 for near-term clues on momentum.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $17.25 | $21.59 | $28.38 | 0% | Neutral | |
| $24.07 | $29.40 | $37.53 | +36% | Bullish | |
| $29.71 | $36.95 | $48.45 | +71% | Bullish | |
| $32.24 | $40.73 | $54.54 | +89% | Bullish | |
| $35.46 | $45.40 | $61.88 | +110% | Bullish | |
| $37.22 | $48.23 | $66.79 | +123% | Bullish | |
| $40.04 | $52.48 | $73.70 | +143% | Bullish | |
| $46.89 | $62.10 | $88.34 | +188% | Bullish | |
| $54.44 | $72.81 | $104.82 | +237% | Bullish | |
| $60.61 | $81.83 | $119.11 | +279% | Bullish | |
| $86.37 | $121.63 | $185.53 | +463% | Bullish | |
| $159.86 | $241.43 | $394.77 | +10.2x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $17.25 | $21.59 | $26.22 | +0.00% |
| August 2026 | $19.14 | $22.40 | $26.80 | +3.76% |
| September 2026 | $18.92 | $22.26 | $26.83 | -0.64% |
| October 2026 | $19.34 | $22.84 | $27.71 | +2.61% |
| November 2026 | $19.75 | $23.41 | $28.57 | +2.52% |
| December 2026 | $19.46 | $23.14 | $28.38 | -1.16% |
Click any year to see its month-by-month HQH forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The HQH price prediction for 2026 points to an average of $21.59 (low $17.25, high $28.38) — a potential gain of 0% on today's $21.59. Price action looks broadly range-bound.
In 2027, HQH is projected to trade between $24.07 and $37.53, averaging $29.40 — a potential gain of +36% from today's $21.59. That is up +36% on the projected 2026 average. Buyers look set to stay in control over this stretch.
Abrdn Healthcare Investors's 2028 outlook centres on $36.95, within a $29.71 to $48.45 range. That is up +26% on the projected 2027 average. That marks a +71% change versus current levels. Momentum favours further upside here.
By 2029, HQH could reach as high as $54.54, with a base case around $40.73 and support toward $32.24 — roughly +89% from $21.59. Buyers look set to stay in control over this stretch.
Expect HQH to range from $35.46 to $61.88 through 2030. The $45.40 average target implies a +110% move from current prices. That is up +11% on the projected 2029 average. Momentum favours further upside here.
The HQH price prediction for 2031 points to an average of $48.23 (low $37.22, high $66.79) — a potential gain of +123% on today's $21.59. Buyers look set to stay in control over this stretch.
In 2032, HQH is projected to trade between $40.04 and $73.70, averaging $52.48 — a potential gain of +143% from today's $21.59. That is up +9% on the projected 2031 average. Momentum favours further upside here.
Abrdn Healthcare Investors's 2033 outlook centres on $62.10, within a $46.89 to $88.34 range. That is up +18% on the projected 2032 average. That marks a +188% change versus current levels. Buyers look set to stay in control over this stretch.
By 2034, HQH could reach as high as $104.82, with a base case around $72.81 and support toward $54.44 — roughly +237% from $21.59. Momentum favours further upside here.
Expect HQH to range from $60.61 to $119.11 through 2035. The $81.83 average target implies a +279% move from current prices. That is up +12% on the projected 2034 average. Buyers look set to stay in control over this stretch.
The HQH price prediction for 2040 points to an average of $121.63 (low $86.37, high $185.53) — a potential gain of +463% on today's $21.59. Momentum favours further upside here.
In 2050, HQH is projected to trade between $159.86 and $394.77, averaging $241.43 — a potential gain of +10.2x from today's $21.59. That is up +99% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in HQH today (≈ 46.31774 HQH) could be worth
$11,182.72
+$10,182.72 (+1018%) by 2050 · US Dollar
Based on the average projected HQH price of $241.43 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in HQHwould be worth at today's price.
$1,000 invested in HQH on Jul 10, 2025 (≈ 62.189055 HQH) would be worth
$1,342.66
+$342.66 (+34.3%) today · 1.34× · US Dollar
Based on a HQH entry price of $16.08 vs. today's $21.59.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $22 | $981.36 | -1.9% |
| 1 month ago | $18.77 | $1,150.24 | +15.0% |
| 3 months ago | $18.96 | $1,138.71 | +13.9% |
| 6 months ago | $19.17 | $1,126.24 | +12.6% |
| 1 year ago | $16.08 | $1,342.66 | +34.3% |
| All time (5.0y) ago | $25.5 | $846.67 | -15.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our HQH forecast.
Our base-case forecast reaches $43.00 around 2030.
Implied market cap at $43.00: $2.46B
The multi-year forecast points to a strong upside trajectory, with the average price rising from $21.63 in 2026 to $44.01 in 2030 and further to $216.10 by 2050. The corresponding ROI figures climb from 0% in 2026 to 103.5% in 2030, then to 414.2% by 2040 and 899.1% by 2050, with sentiment rated bullish in key milestone years.
Specifically, the year-by-year averages include 2027 at $29.35 (ROI 35.7%), 2028 at $36.37 (68.2%), 2029 at $39.19 (81.2%), 2031 at $46.17 (113.5%), 2032 at $49.50 (128.8%), 2033 at $59.31 (174.2%), 2034 at $67.96 (214.2%), and 2035 at $75.78 (250.3%). The path extends to 2040 with an average of $111.22 (ROI 414.2%) and to 2050 with an average of $216.10 (ROI 899.1%). These figures reflect bullish sentiment across the forecast horizon, but they are estimates, not guarantees.
Tap a question to reveal the answer.
Avg $44.01; max $60.03; ROI 103.5%; sentiment BULLISH.
Forecasts show bullish sentiment from 2027 onward with rising average prices and positive ROIs through 2050, but these are estimates and not guarantees.
Yes. The max forecast values show HQH could exceed $100 by 2035 (max $110.34); by 2040 the max is $169.72 and by 2050 the max is $353.43.
Current price is $21.63 and market cap is $1.24B.
Low $20.07; High $23.31.
Abrdn Healthcare Investors Community Discussion
0Share your Abrdn Healthcare Investors price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.